Keywords chronic myelogenic leukemia;K562/MDR1;imatnib mesylate;arsenic trioxide;drug resistant reverse;

• 慢性粒细胞白血病;K562/MDR1;甲磺酸伊马替尼;三氧化二砷;逆转耐药;